Using a halogen bond (XB) donor and Schreiner's thiourea as cooperative catalysts, various amides, including the asparagine residues of several peptides, were directly coupled with glycosyl trichloroacetimidates to give unique N-acylorthoamides in good yields. Synthetic applications of N-acylorthoamides, including rearrangement to the corresponding -N-glycoside, were also demonstrated.
glycofunctionalization of amide, impacting on prodrug synthesis. In fact, during the course of our investigation on the rearrangement of N-acylorthoamide to N-glycoside (path d), we have developed a new type of Brønsted-acid-salt catalyst, comprised of Brønsted acid and 2-halogenated azole, which was found to be an efficient catalyst for the direct N-glycosylation of various amides utilizing the same glycosyl trichloroacetimidates (path b and/or path a and d).
Scheme 1. Summary of this work
We first screened various catalysts for the direct Nglycofunctionalization of a protected asparagine derivative 2a [8] with a readily accessible glycosyl donor 1 [22a] (Table 1 ). The use of Schreiner's thiourea (5) on its own did not promote the reaction at all (entry 1). We next investigated several co-catalysts for activation of thiourea, [19] including metallic Lewis acids (entries 2-5) [11c] and Brønsted acids (entries 6-7). [11a] Interestingly, when a substituted diarylphosphoric acid was employed, an N-acylorthoamide 4a, whose structure was fully characterized using spectral data ( Figure  S5 ), was obtained in 22% yield (entry 6). A stronger Brønsted acid resulted in the production of 3a, albeit in 26% yield (entry 7), indicating that the acidity of the catalyst affects production of 3a. Indeed, as previously reported, with 10 mol % of trimethylsilyl trifluoromethanesulfonate (TMSOTf) [8] as a conventional Lewis acid, the donor 1 was immediately consumed, and 3a was obtained in 25% yield (entry 8), along with several inseparable byproducts. As the results were not satisfactory, we next investigated several XB donors as cooperative catalysts (entries 9-12). We found that combination of thiourea 5 with 2-iodobenzimidazolium-type XB donors 7b [14] afforded 4a as a major product in 66% yield (entry 11). A newly designed XB donor with extended aromatic rings 7c similarly afforded 4a as the major product (entry 12). The XB donor 7b on its own did not afford the target products (entry 13), which indicated that combination of thiourea 5 and XB donor 7b was essential for production of 4a. The yields of 4a greatly decreased when the squaramide [23] 6, which has superior HB-donating ability [23c] to thiourea, [12b,c] was employed instead of 5 (entries 14 and 15). In addition, a control experiment using non-halogenated azolium salt 8 did not afford 4a at all (entry 16). These results suggest that the reaction was not accelerated by the azoliium cation moiety or triflate anion by itself, [24] and that XB formation between the sulfur atom of 5 and the iodine atom of XB donor 7 [15d,18a,b,d] plays an important role for the promotion of the reaction, presumably through the activation of LG (Scheme S1). [25] Although other solvents, such as THF, toluene, and acetonitrile, can be used for this reaction without significant decrease of the chemical yields (entries [17] [18] [19] , CH2Cl2 was chosen for further investigation in terms of the solubility of various amides. To gain further support for the XB formation, a 13 C NMR experiment was performed using thiourea (5) and XB donor (7b) ( Figure S2 ). [25] When 1.0 equivalent of 5 was added, the 13 C NMR peak of the C2 position of 7b broadened and shifted downfield in accordance with previous reports on XB interaction of the iodoazolium salts. [14f-i] It is worth noting that under the optimized condition (Table 1 , entry 11), neither N-trichloroacetylorthoamide nor glycosyl trichloroacetamide were obtained, even additional trichloroacetamide (1.0 equiv) was employed (Scheme 2a), presumably due to the inherent reactivity of the acyloxonium ion intermediate toward nucleophiles. [10] Encouraged by this result, we then investigated the efficient catalysts to promote the rearrangement of 4a to 3a (Scheme 2b). Although the chemical yields of 3a were low using TMSOTf [10c] and TfOH as catalysts, partly because of the degradation of 4a, Brønsted acid salt 9•TfOH, synthesized from the same intermediate for 7c, was found to be most suitable. Having established the synthetic utilities of N-acrylorthoamide 4, we next investigated the substrate scope for glycosyl donors and amides (Scheme 3, 4). Using 10 mol % of catalysts 5 and 7b, N-Cbz-glycineamide (2b) could be directly converted into 4b in 67% yield. Oleamide (2c), which is an important amide towards the synthesis of lipid nanotubes, [2] was effectively conjugated with sugar to afford 4c in 41% yield. Notably, the asparagine residues of dipeptide and tripeptide were glycosylated by the present cocatalytic system to afford 4e and 4f in unprecedented good yields (Scheme 3). The same amides were also coupled with the glucose surrogate utilizing 3,4,6-tri-O-benzyl-2-O-acetyl--D-glucopyranosyl trichloroacetimidate (10) [22b] to yield N-acylorthoamides 11a-f in 56-71% yields (Scheme 4).
We next focused on the direct N-glycosylation utilizing Brønsted acid salt 9•TfOH (Scheme 5), as the acidity of the catalyst was supposed to be important to obtain N-glycoside 3a in Table 1 (entry 7, 8) . To our delight, N-glycoside 12 was obtained in 72% yield, when glycosyl donor 10 and amide 2a were reacted. A slight improvement of the yield was observed when thiourea 5 was employed as co-catalyst. [26] Under the optimized reaction conditions, a series of N-glycoside 12a-f were obtained in 62-82% yields as single -isomers. In addition to the glucose-derived donor 10, a ribose-derived donor 1 could be directly incorporated into amides to afford the corresponding adducts in 45-80% yields. Again, the conjugation with tripeptide proceeded with unprecedented good yields. Notably, the catalyst 9•TfOH could be readily prepared from the commercial source in three steps with high yields, and found to be air-and moisture-stable for several months. The utilities of the present reactions have been clearly demonstrated by their application to the syntheses of natural products [27] (Scheme 6a), and the modification of pharmaceuticals to prodrugs (Scheme 6b). The direct N-glycosylation of a substituted 2-phenylacetamide 2g with glycosyl donor 10 proceeded very smoothly to obtain the desired adduct 12g in excellent yield. The successive deprotection of acetyl and benzyl groups afforded the product in almost quantitative yield (Scheme 6a). The methodologies developed in this paper are particularly useful when the compound to be functionalized has only an amide group for a traceless modification, and this strategy is especially true for pharmaceuticals. For example, the anticancer drug temozolomide (2h) can be transformed into the corresponding N-acylorthoamide 11h using glycosyl donor 10 with 10 mol % of 5 and 7b in THF. After deprotection of the benzyl group of 11h, the product 15h was found to be soluble in protic solvents, such as methanol, while temozolomide itself is almost insoluble. [28] Practically, commercially available glycosyl donor 16 can be converted into the corresponding adduct 17h in 61% yield. It was noted that hydrolysis of the N-adduct 17h under mildly acidic conditions afforded temozolomide (Scheme 6c).
In conclusion, we have developed two different catalytic systems for the synthesis of N-acylorthoamides and N-glycosides with wide functional group tolerance. The XB interaction plays an important role in the production of N-arylorthoamides via the activation of LG under mildly acidic condition. The combination of a XB donor with a relatively soft XB acceptor will allow for otherwise inaccessible transformations, and broaden the utility of XB donor catalysis. In addition, halogenated azolium salts 9•TfOH can be utilized for direct N-glycosylation as novel bench-stable Brønsted acid. Both methodologies will be powerful for the molecular transformation of amides, and offer a new tool for the traceless modification of pharmaceuticals. Further investigation on the details of the reaction mechanism, including complexation of amides, and substrate scope is now underway in our laboratory.
Scheme 6: Application of the present N-glycofunctionalization

Experimental Section
To a stirred solution of glycosyl donor 1 (36.4 mg, 0.06 mmol) and amide 2a (1.0 equiv, 0.05 mmol) in DCM (1.0 mL) was added activated MS 4Å (50 mg), and the reaction mixture was stirred at the ambient temperature for 10 min. Then, the catalysts 5 (2.5 mg, 10 mol %) and 7b (3.5 mg, 10 mol %) were added, and the resulting mixture was stirred at the ambient temperature for 24 hours. After the MS 4Å was filtered off and washed with chloroform, the filtrate was concentrated under reduced pressure to give crude N-acylorthoamide, which was purified by silica gel column chromatography to afford 4a (24.8 mg, 66%), along with 3a (2.6 mg, 7%).
